Sofie Traynor

Sofie Traynor

Auto-generated profile, based on publicly available information

Sofie Traynor

Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Cell Reports
Verified
Journal Article
Open access
RSRasmus Siersbæk
Rasmus Siersbæk
ARAtefeh Rabiee
Atefeh Rabiee
RNRonni Nielsen
Ronni Nielsen
Simone SidoliSimone Sidoli
Simone Sidoli
STSofie Traynor
Sofie Traynor
SMSusanne Mandrup
Susanne Mandrup
It is becoming increasingly clear that transcription factors operate in complex networks through thousands of genomic binding sites, many of which bind several transcription factors. However, the extent and mechanisms of crosstalk between transcription factors at these hotspots remain unclear. Using a combination of advanced proteomics and genomics approaches, we identify ∼12,000 transcription factor hotspots (∼400 bp) in the early phase of adipogenesis, and we find evidence of both simultaneous and sequential binding of transcription factors at these regions. We demonstrate that hotspots are highly enriched in large super-enhancer regions (several kilobases), which drive the early adipogenic reprogramming of gene expression. Our results indicate that cooperativity between transcription factors at the level of hotspots as well as super-enhancers is very important for enhancer activity and transcriptional reprogramming. Thus, hotspots and super-enhancers constitute important regulatory hubs that serve to integrate external stimuli on chromatin.

1 May 2017 in Molecular Cell
Verified
Journal Article
Closed access
RSRasmus Siersbæk
Rasmus Siersbæk
JMJesper Grud Skat Madsen
Jesper Grud Skat Madsen
Biola M. JavierreBiola M. Javierre
Biola M. Javierre
RNRonni Nielsen
Ronni Nielsen
EBEmilie Kristine Bagge
Emilie Kristine Bagge
SMSusanne Mandrup
Susanne Mandrup

1 June 2014 in Cell Reports
Verified
Journal Article
Open access
RSRasmus Siersbæk
Rasmus Siersbæk
SBSongjoon Baek
Songjoon Baek
ARAtefeh Rabiee
Atefeh Rabiee
RNRonni Nielsen
Ronni Nielsen
STSofie Traynor
Sofie Traynor
SMSusanne Mandrup
Susanne Mandrup
Transcription factors have recently been shown to colocalize in hotspot regions of the genome, which are further clustered into super-enhancers. However, the detailed molecular organization of transcription factors at hotspot regions is poorly defined. Here, we have used digital genomic footprinting to precisely define factor localization at a genome-wide level during the early phase of 3T3-L1 adipocyte differentiation, which allows us to obtain detailed molecular insight into how transcription factors target hotspots. We demonstrate the formation of ATF-C/EBP heterodimers at a composite motif on chromatin, and we suggest that this may be a general mechanism for integrating external signals on chromatin. Furthermore, we find evidence of extensive recruitment of transcription factors to hotspots through alternative mechanisms not involving their known motifs and demonstrate that these alternative binding events are functionally important for hotspot formation and activity. Taken together, these findings provide a framework for understanding transcription factor cooperativity in hotspots.

22 May 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
STSofie Traynor
Sofie Traynor
NMNiels Erik Møllegaard
Niels Erik Møllegaard
MJMikkel G Jørgensen
Mikkel G Jørgensen
NBNadine H Brückmann
Nadine H Brückmann
CPChristina B Pedersen
Christina B Pedersen
Morten GjerstorffMorten Gjerstorff
Morten Gjerstorff
Rearrangement of the 1q12 pericentromeric heterochromatin and subsequent amplification of the 1q arm is commonly associated with cancer development and progression and may result from epigenetic deregulation. In many premalignant and malignant cells, loss of 1q12 satellite DNA methylation causes the deposition of polycomb factors and formation of large polycomb aggregates referred to as polycomb bodies. Here, we show that SSX proteins can destabilize 1q12 pericentromeric heterochromatin in melanoma cells when it is present in the context of polycomb bodies. We found that SSX proteins deplete polycomb bodies and promote the unfolding and derepression of 1q12 heterochromatin during replication. This further leads to segregation abnormalities during anaphase and generation of micronuclei. The structural rearrangement of 1q12 pericentromeric heterochromatin triggered by SSX2 is associated with loss of polycomb factors, but is not mediated by diminished polycomb repression. Instead, our studies suggest a direct effect of SSX proteins facilitated though a DNA/chromatin binding, zinc finger-like domain and a KRAB-like domain that may recruit chromatin modifiers or activate satellite transcription. Our results demonstrate a novel mechanism for generation of 1q12-associated genomic instability in cancer cells.

6 January 2024 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
OGOdd L. Gammelgaard
Odd L. Gammelgaard
MTMikkel Terp
Mikkel Terp
AKAlexei F. Kirkin
Alexei F. Kirkin
SJSimone Johansen
Simone Johansen
STSofie Traynor
Sofie Traynor
HDHenrik Ditzel
Henrik Ditzel
Background: Adoptive cell transfer cancer immunotherapy holds promise for treating disseminated disease, yet generating sufficient numbers of lymphocytes with anti-cancer activity against diverse specificities remains a major challenge. We recently developed a novel procedure (ALECSAT) for selecting, expanding and maturating polyclonal lymphocytes from peripheral blood with the capacity to target malignant cells. Methods: Immunodeficient mice were challenged with triple-negative breast cancer cell lines or patient-derived xenografts (PDX) and treated with allogeneic or autologous ALECSAT cells with and without anti-PDL1 therapy to assess the capacity of ALECSAT cells to inhibit primary tumor growth and metastasis. Results: ALECSAT mono therapy inhibited metastasis, but did not inhibit primary tumor growth or prolong survival of tumor-bearing mice. In contrast, combined ALECSAT and anti-PDL1 therapy significantly inhibited primary tumor growth, nearly completely blocked metastasis, and prolonged survival of tumor-bearing mice. Conclusions: Combined ALECSAT and anti-PDL1 therapy results in favorable anti-cancer responses in both cell line-derived xenograft and autologous PDX models of advanced triple-negative breast cancer.

10 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SHSimone Valentin Hansen
Simone Valentin Hansen
STSofie Traynor
Sofie Traynor
HDHenrik Ditzel
Henrik Ditzel
Morten GjerstorffMorten Gjerstorff
Morten Gjerstorff
Drosophila DNA replication-related element binding factor (DREF) is a transcription regulatory factor that binds the promoters of many genes involved in replication and cell proliferation and is required for normal cell cycle progression. Human DREF/zinc finger BED domain-containing protein 1 (ZBED1), an orthologue of Drosophila DREF, also has DNA binding activity, but its cellular functions remain largely uncharacterized. Herein, we show that ZBED1 is a chromatin-associated nuclear protein with a wide expression profile in human tissues from all three primary germ layers. For instance, ZBED1 was expressed in mesodermal-derived epithelial cells of the reproductive system and urinary tract, in endodermal-derived epithelial cells throughout the gastrointestinal tract, and in epidermal epithelium from the ectoderm. ZBED1 was also expressed in connective tissue and smooth muscle cells of multiple organs. To investigate whether ZBED1 is implicated in cell proliferation, similar to Drosophila DREF, we compared the tissue distribution of ZBED1 to that of the proliferation marker Ki-67. ZBED1 and Ki-67 were co-expressed in many epithelial tissues, but ZBED1 expression extended widely beyond that of Ki-67-positive cells. In other tissues, ZBED1 expression was more restricted than Ki-67 expression. These results suggest that ZBED1 is not a cell proliferation-associated factor such as Drosophila DREF, and our study adds to the cumulative understanding of the functions of ZBED1 in human cells and tissues.